Double Regulation of Tonifying-Detoxifing on Elderly Diabetic Coronary Heart Disease After PCI

Fu Xianzhao, Jiang Xiaofeng, Chen Jiajun, Cen Qianli, Li Yuegui, Qiu Haixian
{"title":"Double Regulation of Tonifying-Detoxifing on Elderly Diabetic Coronary Heart Disease After PCI","authors":"Fu Xianzhao, Jiang Xiaofeng, Chen Jiajun, Cen Qianli, Li Yuegui, Qiu Haixian","doi":"10.11648/j.ajbls.20210905.20","DOIUrl":null,"url":null,"abstract":": Objective to investigate the effect of Huoxue Jiedu Jiangtang Recipe (HJJR) on cardiac remodeling and function prognosis in diabetic patients complicated with coronary heart disease (CHD) after percutaneous coronary intervention (PCI), and to explore its possible mechanism. Methods 92 diabetic patients with CHD who had received PCI therapy, were equally randomized into the treatment group (46) and the control group (46) from January 2016 to August 2016. The control group were given standardized western medicine, while treatment group received HJJR besides standardized treatment. The treating course were 2 months. Before and after treatment, the left ventricular morphology index [left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic ventricular septal thickness (LVEST)] and the cardiac function data [stroke volume (SV), left ventricular fractional shortening (FS), the cardiac index (CI), cardiac output (CO), maximum blood flow velocity of early diastolic/ atrium late diastolic (E/A), left ventricle ejection fraction (EF)] were detected with echocardiography. The serum levels of C-reactive protein (CRP), tumor necrosis factor-a (TNF-α), interleukin-6 (IL-6) and Angiotensin II (Ang II) were tested with enzyme linked immunosorbent assay (ELISA), and the clinical efficacy and 5-year survival rate were evaluated. Results The total clinical effective rate and 5-year survival ratio in treatment group were higher than those in control group (P<0.05). Serum inflammatory mediators (CRP, IL-6, TNF-α) and Ang II decreased more than that in the control group (all P<0.05); And in treatment group, the left ventricular morphology index (LVESD, LVEDD) decreased more than that in the control group, while the cardiac function indexes (∆ FS, CO, CI, SV, LVEF, E/A) were increased more in treatment group. Conclusion HJJR can hold back the deterioration of heart restructure, improve heart function, ameliorate prognosis and prolong living in diabetic CHD after PCI, and its partial therapeutic effects might come from its reducing the level of Ang II and anti-inflammatory function.","PeriodicalId":7857,"journal":{"name":"American Journal of Biomedical and Life Sciences","volume":"70 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Biomedical and Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/j.ajbls.20210905.20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Objective to investigate the effect of Huoxue Jiedu Jiangtang Recipe (HJJR) on cardiac remodeling and function prognosis in diabetic patients complicated with coronary heart disease (CHD) after percutaneous coronary intervention (PCI), and to explore its possible mechanism. Methods 92 diabetic patients with CHD who had received PCI therapy, were equally randomized into the treatment group (46) and the control group (46) from January 2016 to August 2016. The control group were given standardized western medicine, while treatment group received HJJR besides standardized treatment. The treating course were 2 months. Before and after treatment, the left ventricular morphology index [left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic ventricular septal thickness (LVEST)] and the cardiac function data [stroke volume (SV), left ventricular fractional shortening (FS), the cardiac index (CI), cardiac output (CO), maximum blood flow velocity of early diastolic/ atrium late diastolic (E/A), left ventricle ejection fraction (EF)] were detected with echocardiography. The serum levels of C-reactive protein (CRP), tumor necrosis factor-a (TNF-α), interleukin-6 (IL-6) and Angiotensin II (Ang II) were tested with enzyme linked immunosorbent assay (ELISA), and the clinical efficacy and 5-year survival rate were evaluated. Results The total clinical effective rate and 5-year survival ratio in treatment group were higher than those in control group (P<0.05). Serum inflammatory mediators (CRP, IL-6, TNF-α) and Ang II decreased more than that in the control group (all P<0.05); And in treatment group, the left ventricular morphology index (LVESD, LVEDD) decreased more than that in the control group, while the cardiac function indexes (∆ FS, CO, CI, SV, LVEF, E/A) were increased more in treatment group. Conclusion HJJR can hold back the deterioration of heart restructure, improve heart function, ameliorate prognosis and prolong living in diabetic CHD after PCI, and its partial therapeutic effects might come from its reducing the level of Ang II and anti-inflammatory function.
老年糖尿病冠心病PCI术后补毒双重调节作用的研究
目的探讨活血解毒降糖方(HJJR)对糖尿病合并冠心病(CHD)患者经皮冠状动脉介入治疗(PCI)后心脏重构及功能预后的影响,并探讨其可能的机制。方法2016年1月至2016年8月,将92例接受PCI治疗的糖尿病合并冠心病患者随机分为治疗组(46例)和对照组(46例)。对照组给予规范化西药治疗,治疗组在规范化治疗的基础上给予HJJR治疗。疗程2个月。治疗前后左室形态学指标[左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD)、左室后壁厚度(LVPWT)、左室舒张末期室间隔厚度(LVEST)]及心功能指标[卒中容积(SV)、左室分数缩短(FS)、心脏指数(CI)、心输出量(CO)、超声心动图检测舒张早期/舒张晚期心房最大血流速度(E/A)、左心室射血分数(EF)。采用酶联免疫吸附法(ELISA)检测两组患者血清c反应蛋白(CRP)、肿瘤坏死因子-α (TNF-α)、白细胞介素-6 (IL-6)、血管紧张素II (Ang II)水平,并评估临床疗效和5年生存率。结果治疗组患者临床总有效率和5年生存率均高于对照组(P<0.05)。血清炎症介质(CRP、IL-6、TNF-α)、Angⅱ降低幅度均大于对照组(P<0.05);治疗组左室形态指数(LVESD、LVEDD)下降幅度大于对照组,心功能指数(∆FS、CO、CI、SV、LVEF、E/A)升高幅度大于对照组。结论HJJR可抑制糖尿病性冠心病PCI术后心脏结构恶化,改善心功能,改善预后,延长生存期,其部分治疗作用可能与降低angii水平及抗炎功能有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信